Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AMGN | VRTX | REGN | GILD |
| Company | Intra-Cellular Ther | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 75.20 | 336.30 | 490.73 | 1,082.48 | 72.35 |
| High | 75.20 | 336.30 | 495.79 | 1,082.48 | 72.35 |
| Low | 75.20 | 336.30 | 489.07 | 1,082.48 | 72.35 |
| Last | 75.20 | 336.30 | 491.57 | 1,082.48 | 72.35 |
| Change | +0.34 | +5.01 | +3.45 | +18.88 | -0.21 |
| % Change | +0.45% | +1.51% | +0.71% | +1.78% | -0.29% |
| Volume | 1,107 | 5,342 | 1,691,700 | 7,827 | 26,650 |
| 20-Day Average Volume | 1,564,575 | 2,002,272 | 1,232,580 | 411,391 | 6,236,598 |
| Previous Close | 74.86 | 331.29 | 488.12 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 73.59 | 321.05 | 480.54 | 1,065.00 | 69.78 |
| 20-Day Raw Stochastic | 65.64% | 91.85% | 83.53% | 74.94% | 71.16% |
| 20-Day Relative Strength | 56.32% | 68.73% | 65.52% | 60.39% | 62.42% |
| Weighted Alpha | +27.39 | +42.28 | +40.92 | +44.68 | -4.91 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.44% since 07/15/24 | +1.86% since 07/15/24 | +0.58% since 07/12/24 | +0.03% since 07/15/24 | +2.17% since 07/15/24 |
| Low | 74.45 on 07/18/24 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 79.88 on 07/16/24 | 338.98 on 07/18/24 | 496.93 on 07/16/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | -1.80% since 06/21/24 | +9.13% since 06/21/24 | +5.20% since 06/18/24 | +2.79% since 06/21/24 | +2.38% since 06/21/24 |
| Low | 66.26 on 07/01/24 | 306.11 on 07/03/24 | 463.23 on 06/20/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 79.88 on 07/16/24 | 338.98 on 07/18/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | +0.89% since 04/22/24 | +23.68% since 04/22/24 | +24.68% since 04/19/24 | +20.25% since 04/22/24 | +8.07% since 04/22/24 |
| Low | 64.09 on 05/20/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 79.88 on 07/16/24 | 338.98 on 07/18/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | +11.71% since 01/22/24 | +8.43% since 01/22/24 | +13.00% since 01/19/24 | +14.81% since 01/22/24 | -7.75% since 01/22/24 |
| Low | 62.78 on 02/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 84.89 on 04/16/24 | 338.98 on 07/18/24 | 496.93 on 07/16/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,903,344 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 105,575 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 464,370,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -139,670,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 144,870,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -15,250,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 1.01 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |